Preliminary Program
Stream 3: Frontiers of Clinical Oncology
Forum 3-1: Lung Cancer |
|
Day 2: Morning, May 09, 2023 |
|
Chair |
Dr. Nicolas Paleiron, Respiratory Disease Unit, HIA Sainte Anne, France |
Co-chair | Call for Co-chair |
Time |
Speeches and Speakers |
08:30-08:35 |
Chair’s Introduction |
08:35-09:00 |
|
09:00-09:25 |
Title: TBD |
09:25-09:50 |
Title: TBD |
09:50-10:15 |
Title: TBD |
10:15-10:30 |
Coffee Break |
10:30-10:55 |
Title: TBD |
10:55-11:20 |
Title: TBD |
11:20-11:45 |
Title: TBD |
11:45-12:10 |
Speech Opportunity Available |
Forum 3-2: Breast Cancer |
|
Day 2: Morning, May 09, 2023 |
|
Chair |
Call for Chair |
Co-chair | Call for Co-chair |
Time |
Speeches and Speakers |
08:30-08:35 |
Chair’s Introduction |
08:35-09:00 |
Title: TBD |
09:00-09:25 |
Title: TBD |
09:25-09:50 |
Title: TBD |
09:50-10:15 |
Title: Immunohistochemical Expression of Cancer/Testis Antigens MAGE-A and NY-ESO-1 in Tumors Dr. Antonije Juretic, School of Medicine, University of Zagreb and University Hospital "Sveti Duh", Croatia |
10:15-10:30 |
Coffee Break |
10:30-10:55 |
Speech Opportunity Available |
10:55-11:20 |
Title: TBD |
11:20-11:45 |
Title: TBD |
11:45-12:10 |
Speech Opportunity Available |
Forum 3-3: Brain, Head, Oral and Neck Cancer |
|
Day 2: Morning, May 09, 2023 |
|
Chair |
Call for Chair |
Co-chair | Call for Co-chair |
Time |
Speeches and Speakers |
08:30-08:35 |
Chair’s Introduction |
08:35-09:00 |
Title: TBD |
09:00-09:25 |
Title: TBD Dr. Christie Bialowas, Associate Professor, Albany Medical Center, Albany, USA |
09:25-09:50 |
Title: New Analogue of Curcuma ( PAC) and It Potential Preclinical Application for Oral Cancer Therapy Dr. Abdelhabib Semlali, Professor, Laval University, Canada |
09:50-10:15 |
Title: TBD Dr. Terry Lichtor, Associate Professor, Rush University Medical Center, USA |
10:15-10:30 |
Coffee Break |
10:30-10:55 | Title: TBD Dr. Xiaohong Chen, Professor, Beijing Tongren Hospital, Capital Medical University, China |
10:55-11:20 | Speech Opportunity Available |
11:20-11:45 | Speech Opportunity Available |
11:45-12:10 | Speech Opportunity Available |
Forum 3-4: GI Cancers: Gastroesophageal, Pancreatic, Hepatobiliary, Colorectal, and Anal Cancers |
|
Day 2: Morning, May 09, 2023 |
|
Chair |
Dr. Mingliang He, Professor, City University of Hong Kong, China |
Co-chair |
Dr. Eran Sadot, Professor of Surgery, Tel Aviv University, Israel |
Time |
Speeches and Speakers |
08:30-08:35 |
Chair’s Introduction |
08:35-09:00 |
Title: TBD Dr. Sebastian F. Schoppmann, Professor, Medical University of Vienna, Austria
|
09:00-09:25 |
Title: Colon Cancer: the Roles of Gut Microbiota |
09:25-09:50 |
Title: Dimethyl Fumarate is Repurposed as an Alternative Drug for Treating Hepatocellular Carcinoma |
09:50-10:15 |
Title: Immunotherapy and the Management of Colorectal Liver Metastases |
10:15-10:30 |
Coffee Break |
10:30-10:55 |
Title: TBD Dr. Luciano Tracia, Director, Advanced Technologies "G. Ingrassia", University of Catania, Italy |
10:55-11:20 |
Title: TBD Dr. Antonio Cubillo, Head of the Department of Medical Oncology, the Centro Integral Oncológico Clara Campal,Spain |
11:20-11:45 |
Title: TBD |
11:45-12:10 |
Speech Opportunity Available |
Forum 3-5: Liver Cancer |
|
Day 2: Afternoon, May 09, 2023 |
|
Chair |
Call for Chair |
Co-chair | Call for Co-chair |
Time |
Speeches and Speakers |
13:30-13:35 |
Chair’s Introduction |
13:35-14:05 |
Title: TBD |
14:05-14:30 |
Title: TBD |
14:30-14:55 |
Title: TBD |
14:55-15:20 |
Speech Opportunity Available |
15:20-15:35 |
Coffee Break |
15:35-16:00 | Title: TBD Dr. Muhammad Anwar, Al Badar Medical Center, Pakistan |
16:00-16:25 | Title: TBD Dr. Mohamed Fathey Abdelkhalek Elgazzar, Menofia University, Spain |
16:25-16:50 | Speech Opportunity Available |
16:50-17:15 | Speech Opportunity Available |
Forum 3-6: Genitourinary, Kidney, Bladder, Prostate, Testicular, and Penile Cancers |
|
Day 2: Afternoon, May 09, 2023 |
|
Chair |
Call for Chair |
Co-chair | Call for Co-chair |
Time |
Speeches and Speakers |
13:30-13:35 |
Chair’s Introduction |
13:35-14:05 |
Title: TBD |
14:05-14:30 |
Title: Molecular Classification of Aggressive Bladder Cancer Histologic Variants Dr. Charles C. Guo, Professor of Pathology, University of Texas MD Anderson Cancer Center, USA |
14:30-14:55 |
Title: TBD Dr. Anita K Patel, Program Director, Henry Ford Health System, USA |
14:55-15:20 |
Title: Anticancer Effects of New Peptide HS1001 Targeted on hTERT in Prostate Cancer Cells Dr. Hyung Sik Kim, Professor, Department of Pharmacy, Sungkyunkwan University, Korea
|
15:20-15:35 |
Coffee Break |
15:35-16:00 |
Title: The Androgen Receptor/Filamin a Complex as a Playmaker in Prostate Cancer-associated fibroblasts(CAFs) Dr. Marzia Di Donato, Department of Precision Medicine, University of Campania 'L. Vanvitelli'- Via L. De Crecchio, Italy (Video Presentation) |
16:00-16:25 | Speech Opportunity Available |
16:25-16:50 | Title: TBD Dr. Premkumar Saganti, Regent's Professor, Prairie View A&M University, USA |
16:50-17:15 | Title: TBD Dr. Eriko Nakano, St. Luke’s International Hospital, Japan |
Forum 3-7: Gastrointestinal Cancer |
|
Day 2: Afternoon, May 09, 2023 |
|
Chair |
Call for Chair |
Co-chair | Call for Co-chair |
Time |
Speeches and Speakers |
13:30-13:35 |
Chair’s Introduction |
13:35-14:05 |
Title: TBD |
14:05-14:30 |
Title: TBD |
14:30-14:55 |
Speech Opportunity Available |
14:55-15:20 |
Title: TBD Dr. Fang-fang Liu, Associate Professor, Peking University, China |
15:20-15:35 |
Coffee Break |
15:35-16:00 | Speech Opportunity Available |
16:00-16:25 | Speech Opportunity Available |
16:25-16:50 | Speech Opportunity Available |
16:50-17:15 | Speech Opportunity Available |
Forum 3-8: Gynecologic Cancer |
|
Day 2: Afternoon, May 09, 2023 |
|
Chair |
Call for Chair |
Co-chair | Call for Co-chair |
Time |
Speeches and Speakers |
13:30-13:35 |
Chair’s Introduction |
13:35-14:05 |
Title: TBD |
14:05-14:30 |
Title: Management of Uterine Leiomyosarcoma: Status of Art and Perspectives of Clinical Research Dr. Angiolo Gadducci, Professor, University of Pisa, Italy |
14:30-14:55 |
Title: TBD Dr. Ronit Abir, Professor, Tel Aviv University, Israel |
14:55-15:20 |
Title: Compound 3K, a Specific Pyruvate Kinase M2 Inhibitor, Induces Autophagic Cell Death through the Disruption of the Glycolytic Pathway in Ovarian Cancer Cells |
15:20-15:35 |
Coffee Break |
15:35-16:00 | Title: Tailoring Management of Patients with Early Cervical Dr. Ofer Gemer, Professor, Ben-Gurion University, Israel |
16:00-16:25 | Title: Chemo- and Radio-Therapy Free Era for Cancer Treamtment Dr. Shu-Lin Liu, Harbin Medical University, China |
16:25-16:50 | Title: Single-Institution Retrospective Analysis of Ovarian Cancer Outcomes from the Middle Eastern Republic of Georgia Dr. Nino Vardiashvili, Innova Medical Center, Georgia |
16:50-17:15 | Title: Hysteroscopic Endometrial Resection for Diagnosis of a High-grade Endometrial Stromal Sarcoma In Cesarean Section Scar Dr. Chang Sheng Yin, Kang Ning Hospital, Taiwan, China |
Forum 3-9: Hematologic Malignancies |
|
Day 3: Morning, May 10, 2023 |
|
Chair |
Call for Chair |
Co-chair | Call for Co-chair |
Time |
Speeches and Speakers |
08:30-08:35 |
Chair’s Introduction |
08:35-09:00 |
Title: Venous Diseases in Malignancy Dr. Joshua Kuban, University of Texas MD Anderson Cancer Center, Baylor College of Medicine, USA |
09:00-09:25 |
Title: TBD Dr. Douglas W. Sborov, Director, Huntsman Cancer Institute, University of Utah, USA |
09:25-09:50 |
Title: TBD Dr. Hakan Brorson, Adjunct Professor, Lund University Cancer Center, Sweden |
09:50-10:15 |
Title: TBD Dr. Nobuyoshi Arima, Director, Shinko Hospital; Medical Research Institute Kitano Hospital, Japan |
10:15-10:30 |
Coffee Break |
10:30-10:55 |
Title: TBD Dr. Bunyamin Isik, Director, Hacettepe University, Turkey |
10:55-11:20 |
Title: TBD Dr. Changying Jiang, Assistant Professor, Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, USA |
11:20-11:45 |
Title: Minimal Residual Disease Detection in Acute Leukemia: Clinical Significance and Technical Challenges Dr. Weijie Li, Assistant Professor, Children's Mercy Hospitals and Clinics, USA |
11:45-12:10 |
Title: Massive Cell Apoptosis as A Consequence of Extra Activation of Ras |
Forum 3-10: Melanoma/Skin Cancers and Sarcoma |
|
Day 3: Morning, May 12, 2023 |
|
Chair |
Call for Chair |
Co-chair | Call for Co-chair |
Time |
Speeches and Speakers |
08:30-08:35 |
Chair’s Introduction |
08:35-09:00 |
Title: TBD |
09:00-09:25 |
Title: TBD |
09:25-09:50 |
Speech Opportunity Available |
09:50-10:15 |
Title: TBD |
10:15-10:30 |
Coffee Break |
10:30-10:55 | Speech Opportunity Available |
10:55-11:20 | Title: TBD Dr. Avneet Garg, Adesh Institute of Medical Sciences and Resaerch, India |
11:20-11:45 | Title: TBD Dr. Dognming Li, Associate Professor, Peking University Third Hospital, China |
11:45-12:10 | Speech Opportunity Available |
Forum 3-11: Pediatric Oncology |
|
Day 3: Morning, May 10, 2023 |
|
Chair |
Call for Chair |
Co-chair | Call for Co-chair |
Time |
Speeches and Speakers |
08:30-08:35 |
Chair’s Introduction |
08:35-09:00 |
Speech Opportunity Available |
09:00-09:25 |
Speech Opportunity Available |
09:25-09:50 |
Speech Opportunity Available |
09:50-10:15 |
Speech Opportunity Available |
10:15-10:30 |
Coffee Break |
10:30-10:55 | Speech Opportunity Available |
10:55-11:20 | Speech Opportunity Available |
11:20-11:45 | Speech Opportunity Available |
11:45-12:10 | Speech Opportunity Available |
Forum 3-12: Geriatric Oncology |
|
Day 3: Morning, May 10, 2023 |
|
Chair |
Call for Chair |
Co-chair | Call for Co-chair |
Time |
Speeches and Speakers |
08:30-08:35 |
Chair’s Introduction |
08:35-09:00 |
Title: TBD Dr. Najia Musolino, Chief Executive Officer, International Society of Geriatric Oncology, Switzerland |
09:00-09:25 |
Title: TBD |
09:25-09:50 |
Speech Opportunity Available |
09:50-10:15 |
Speech Opportunity Available |
10:15-10:30 |
Coffee Break |
10:30-10:55 | Speech Opportunity Available |
10:55-11:20 | Speech Opportunity Available |
11:20-11:45 | Speech Opportunity Available |
11:45-12:10 | Speech Opportunity Available |
Forum 3-13: Bone Cancer |
|
Day 3: Afternoon, May 10, 2023 |
|
Chair |
Call for Chair |
Co-chair | Call for Co-chair |
Time |
Speeches and Speakers |
13:30-13:35 |
Chair’s Introduction |
13:35-14:05 |
Title: TBD |
14:05-14:30 |
Speech Opportunity Available |
14:30-14:55 |
Speech Opportunity Available |
14:55-15:20 |
Speech Opportunity Available |
15:20-15:35 |
Coffee Break |
15:35-16:00 | Speech Opportunity Available |
16:00-16:25 | Speech Opportunity Available |
16:25-16:50 | Speech Opportunity Available |
16:50-17:15 | Speech Opportunity Available |
Forum 3-14: Care Delivery and Regulatory Policy |
|
Day 3: Afternoon, May 10, 2023 |
|
Chair |
Call for Chair |
Co-chair | Call for Co-chair |
Time |
Speeches and Speakers |
13:30-13:35 |
Chair’s Introduction |
13:35-14:05 |
Title: Oncologic Emergency Medicine--caring for the sickest oncology patients; an emerging subspecialty Dr. Monica K. Wattana, Associate Professor, UT MD Anderson Cancer Center, USA |
14:05-14:30 |
Title: TBD Dr. Yuchan Li, Professor, National Taipei University of Nursing and Health Sciences, Taiwan |
14:30-14:55 |
Title: Hushed Voices and Private Spaces: Fortifying the Role of Qualitative Methodologies in Cancer Research Dr. Maria Minerva P Calimag, Professor, University of Santo Tomas Philippine |
14:55-15:20 |
Title: TBD |
15:20-15:35 |
Coffee Break |
15:35-16:00 | Title: TBD Dr. Amlaiev KR, Stavropol State Medical University, Russia |
16:00-16:25 | Title: TBD Dr. Marcello Migliore, Professor, University of Catania, Italy |
16:25-16:50 | Title: RCT Exploring the use of Virtual Reality as an Adjunctive Measure for Cancer Pain Dr. Bernie Garrett, Associate Professor, University of British Columbia, Canada |
16:50-17:15 | Title: Person-centered Palliative Care In Long Term Care Settings: Measuring Well-Dying As a Patient Reported Outcome Dr. So-Hi Kwon, Professor, Kyungpook National University, College of Nursing, South Korea |
Contact Us: Email:Mandy@bitcongress.com
Company Name: 3F, Building 2, Dalian Life Science Innovation Center, 43 Huoju Road,
Hi-tech Industrial Zone, Dalian City, Liaoning Province, China
Copyright © 2008-2022 BIT Congress